Pan-Chyr Yang

Pan-Chyr Yang

Auto-generated profile, based on publicly available information

Pan-Chyr Yang

Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

2 June 2005 in Cancer
Verified
Journal Article
Open access
PDF file
KCKuan‐Yu Chen
Kuan‐Yu Chen
CCChia‐Hsuin Chang
Chia‐Hsuin Chang
CYChong-Jen Yu
Chong-Jen Yu
SKSow‐Hsong Kuo
Sow‐Hsong Kuo
PYPan‐Chyr Yang
Pan‐Chyr Yang
BACKGROUND: The results from previous studies suggested that the clinical characteristics and outcomes of patients with lung carcinoma vary between gender and age groups. The objective of the current study was to assess the trend in the evolution of the histologic types in Taiwan and to compare the outcomes of patients with lung carcinoma between different gender and age groups.METHODS: Patients with primary lung carcinoma were identified through the cancer registry system. Clinical records were reviewed and analyzed for age, gender, disease stage, histology, treatment modalities, and survival. A multivariate analysis using a Cox proportional hazards model was applied for gender, age (by decade), histologic type, disease stage, and treatment modality.RESULTS: Between 1991–1999, 2714 patients with histologically or cytologically proven lung carcinoma were included. Adenocarcinoma was the major cell type of lung carcinoma (52.5%), with a significant trend toward an increase in adenocarcinoma during the study period. A significantly high percentage of adenocarcinoma was demonstrated in female patients (73.5%), who also had better survival compared with male patients (P = 0.002), especially in the group age 50–69 years. Patients age < 40 years also had a poor prognosis, which was worse compared with the prognosis for patients age 40–59 years. patients who had adenocarcinoma had a better survival rate compared with patients who had other histologic types (relative risk, 0.78; 95% confidence interval, 0.69–0.87).CONCLUSIONS: Adenocarcinoma was predominant in female patients and emerged as a greater problem than other histologic types in Taiwan, potentially raising the importance of studies regarding the benefit of population diversity in new antitumor therapies, such as gefitinib. Female patients with lung carcinoma had a better prognosis than male patients in the group age 50–69 years, warranting further studies on potential prognostic factors associated with middle age, such as hormone status. Cancer 2005. © 2005 American Cancer Society.

1 July 2003
Verified
Journal Article
Closed access
YKYu-Rong Kao
Yu-Rong Kao
JSJin-Yuan Shih
Jin-Yuan Shih
WWWei-Chun Wen
Wei-Chun Wen
YKYa-Ping Ko
Ya-Ping Ko
BCBing-Mae Chen
Bing-Mae Chen
SRSteve R Roffler
Steve R Roffler

18 August 2006 in Cancer Letters
Verified
Journal Article
Closed access
KCKuan-Yu Chen
Kuan-Yu Chen
LLLi-Na Lee
Li-Na Lee
CYChong-Jen Yu
Chong-Jen Yu
YLYung-Chie Lee
Yung-Chie Lee
SKSow-Hsong Kuo
Sow-Hsong Kuo
PYPan-Chyr Yang
Pan-Chyr Yang

31 March 2007 in European Journal of Cancer
Verified
Journal Article
Closed access
PDF file
KCKuan-Yu Chen
Kuan-Yu Chen
YLYuan-Chii Gladys Lee
Yuan-Chii Gladys Lee
JLJin-Mei Lai
Jin-Mei Lai
YCYih-Leong Chang
Yih-Leong Chang
YLYung-Chie Lee
Yung-Chie Lee
PYPan-Chyr Yang
Pan-Chyr Yang

1 July 2006
Verified
Journal Article
Closed access
GCGee-Chen Chang
Gee-Chen Chang
CTChun-Ming Tsai
Chun-Ming Tsai
KCKun-Chieh Chen
Kun-Chieh Chen
CYChong-Jen Yu
Chong-Jen Yu
JSJin-Yuan Shih
Jin-Yuan Shih
JYJames Chih-Hsin Yang
James Chih-Hsin Yang